These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 29797950
1. [Preliminary findings for metabolite profiles of papillary thyroid carcinoma and laryngeal squamous cell carcinoma]. Fei MJ, Xu YN, Wang JD. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct 20; 31(20):1561-1565. PubMed ID: 29797950 [Abstract] [Full Text] [Related]
2. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma. Xu Y, Zheng X, Qiu Y, Jia W, Wang J, Yin S. J Proteome Res; 2015 Aug 07; 14(8):3315-21. PubMed ID: 26130307 [Abstract] [Full Text] [Related]
4. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy. Shang X, Zhong X, Tian X. Tumour Biol; 2016 Aug 07; 37(8):11163-75. PubMed ID: 26935059 [Abstract] [Full Text] [Related]
5. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study. Li Y, Chen M, Liu C, Xia Y, Xu B, Hu Y, Chen T, Shen M, Tang W. Int J Mol Med; 2018 May 07; 41(5):3006-3014. PubMed ID: 29484373 [Abstract] [Full Text] [Related]
6. GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue. Chen M, Shen M, Li Y, Liu C, Zhou K, Hu W, Xu B, Xia Y, Tang W. Int J Mol Med; 2015 Dec 07; 36(6):1607-14. PubMed ID: 26459747 [Abstract] [Full Text] [Related]
7. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma. Huang FQ, Li J, Jiang L, Wang FX, Alolga RN, Wang MJ, Min WJ, Ma G, Zhao YJ, Wang SL, Yu Y, Chen X, Zhu D, Zhu J, Wang G, Xia T, Sang JF, Lai MD, Li P, Zhu W, Qi LW. Int J Cancer; 2019 Feb 15; 144(4):868-876. PubMed ID: 30318614 [Abstract] [Full Text] [Related]
8. Metabolomic Alterations in Thyrospheres and Adherent Parental Cells in Papillary Thyroid Carcinoma Cell Lines: A Pilot Study. Caria P, Tronci L, Dettori T, Murgia F, Santoru ML, Griffin JL, Vanni R, Atzori L. Int J Mol Sci; 2018 Sep 27; 19(10):. PubMed ID: 30262749 [Abstract] [Full Text] [Related]
9. A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma. Shen CT, Zhang Y, Liu YM, Yin S, Zhang XY, Wei WJ, Sun ZK, Song HJ, Qiu ZL, Wang CR, Luo QY. Clin Endocrinol (Oxf); 2017 Dec 27; 87(6):844-852. PubMed ID: 28755525 [Abstract] [Full Text] [Related]
10. Identifying potential metabolic tissue biomarkers for papillary thyroid cancer in different iodine nutrient regions. Sun Q, Zhao H, Liu Z, Wang F, He Q, Xiu C, Guo L, Tian Q, Fan L, Sun J, Sun D. Endocrine; 2021 Dec 27; 74(3):582-591. PubMed ID: 34075541 [Abstract] [Full Text] [Related]
11. Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma. Wang Z, Yang Y, Xing Y, Si D, Wang S, Lin J, Li C, Zhang J, Yin D. Sci Rep; 2023 Oct 17; 13(1):17666. PubMed ID: 37848492 [Abstract] [Full Text] [Related]
12. Expression of polysialic acid in primary laryngeal squamous cell carcinoma. Klobučar M, Visentin S, Jakovčević A, Bilić M, Kovač-Bilić L, Đanić D, Pavelić K, Kraljević Pavelić S. Life Sci; 2017 Mar 15; 173():73-79. PubMed ID: 28185819 [Abstract] [Full Text] [Related]
13. Collision tumor of the thyroid and larynx: a patient with papillary thyroid carcinoma colliding with laryngeal squamous cell carcinoma. Jacobson AS, Wenig BM, Urken ML. Thyroid; 2008 Dec 15; 18(12):1325-8. PubMed ID: 19067640 [Abstract] [Full Text] [Related]
14. PDLIM5 identified by label-free quantitative proteomics as a potential novel biomarker of papillary thyroid carcinoma. Wei X, Zhang Y, Yu S, Li S, Jiang W, Zhu Y, Xu Y, Yang C, Tian G, Mi J, Bergquist J, Zhao M, Song F. Biochem Biophys Res Commun; 2018 May 05; 499(2):338-344. PubMed ID: 29574154 [Abstract] [Full Text] [Related]
16. [Expression and clinical significance of long non-coding RNA LINC00520 in laryngeal squamous cell carcinoma]. Wu YY, Gao W, Zhang YL, Niu M, Cui JJ, Xiang CX, Sang JW, Wen SX, Wang BQ. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan 20; 32(2):91-95. PubMed ID: 29757551 [Abstract] [Full Text] [Related]
17. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma]. Yue C, Zhao X, Tian C, Jin Y, Liu H. Zhonghua Bing Li Xue Za Zhi; 2015 Jul 20; 44(7):490-4. PubMed ID: 26705040 [Abstract] [Full Text] [Related]
18. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma. Nam KH, Noh TW, Chung SH, Lee SH, Lee MK, Hong SW, Chung WY, Lee EJ, Park CS. Thyroid; 2011 Jul 20; 21(7):745-50. PubMed ID: 21615302 [Abstract] [Full Text] [Related]
19. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma. Zhao S, Wang Q, Li Z, Ma X, Wu L, Ji H, Qin G. J Exp Clin Cancer Res; 2015 Dec 04; 34():146. PubMed ID: 26637328 [Abstract] [Full Text] [Related]
20. Metabolic Profiles and Blood Biomarkers to Discriminate between Benign Thyroid Nodules and Papillary Carcinoma, Based on UHPLC-QTOF-ESI+-MS Analysis. Berinde GM, Socaciu AI, Socaciu MA, Petre GE, Socaciu C, Piciu D. Int J Mol Sci; 2024 Mar 20; 25(6):. PubMed ID: 38542465 [Abstract] [Full Text] [Related] Page: [Next] [New Search]